Vanfund Urban Investment and Development Co., Ltd. (SHE:000638)
1.150
-0.060 (-4.96%)
Apr 3, 2026, 3:04 PM CST
SHE:000638 Revenue
Vanfund Urban Investment and Development had revenue of 22.97M CNY in the quarter ending September 30, 2025, a decrease of -62.42%. This brings the company's revenue in the last twelve months to 457.59M, up 161.25% year-over-year. In the year 2024, Vanfund Urban Investment and Development had annual revenue of 391.47M with 133.70% growth.
Revenue (ttm)
457.59M
Revenue Growth
+161.25%
P/S Ratio
0.78
Revenue / Employee
2.91M
Employees
157
Market Cap
358.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 391.47M | 223.96M | 133.70% |
| Dec 31, 2023 | 167.51M | 9.80M | 6.22% |
| Jan 1, 2023 | 157.71M | -164.73M | -51.09% |
| Jan 1, 2022 | 322.43M | 211.44M | 190.50% |
| Dec 31, 2020 | 110.99M | -4.69M | -4.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.42B |
| Shenzhen Mindray Bio-Medical Electronics | 33.28B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.63B |
| Sichuan Biokin Pharmaceutical | 2.52B |
| Tiansheng Pharmaceutical Group | 516.17M |
| Suzhou Iron Technology CO.,LTD | 452.49M |
| Qinghai Spring Medicinal Resources Technology | 284.76M |
| AVE Science&Technology CO.,LTD | 230.03M |